Shanghai GenTech Co., Ltd.
SSE:688596.SS
36.85 (CNY) • At close May 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,469.338 | 3,834.736 | 2,704.743 | 1,836.764 | 1,108.985 | 1,185.705 | 920.632 | 707.163 | 580.207 | 511.539 | 498.309 | 216.067 |
| Cost of Revenue
| 4,045.947 | 2,795.01 | 1,962.056 | 1,356.012 | 805.966 | 885.155 | 679.964 | 557.439 | 463.68 | 401.876 | 384.251 | 160.24 |
| Gross Profit
| 1,423.391 | 1,039.726 | 742.686 | 480.753 | 303.02 | 300.549 | 240.668 | 149.724 | 116.527 | 109.663 | 114.058 | 55.827 |
| Gross Profit Ratio
| 0.26 | 0.271 | 0.275 | 0.262 | 0.273 | 0.253 | 0.261 | 0.212 | 0.201 | 0.214 | 0.229 | 0.258 |
| Reseach & Development Expenses
| 0 | 251.024 | 149.908 | 78.221 | 52.49 | 45.987 | 39.588 | 32.038 | 0 | 0 | 25.005 | 13.597 |
| General & Administrative Expenses
| 0 | 112.401 | 104.291 | 60.628 | 31.645 | 26.4 | 17.915 | 16.034 | 70.707 | 65.807 | 67.273 | 53.903 |
| Selling & Marketing Expenses
| 0 | 35.748 | 47.779 | 40.746 | 23.026 | 30.688 | 19.505 | 15.814 | 13.66 | 14.022 | 13.209 | 13.094 |
| SG&A
| 140.89 | 148.149 | 152.07 | 101.374 | 54.671 | 57.087 | 37.42 | 31.847 | 84.367 | 79.828 | 80.482 | 66.997 |
| Other Expenses
| 338.001 | -71.272 | 152.62 | 115.635 | 72.363 | 77.619 | -0.475 | 0.047 | 0 | 0 | 4.96 | 2.523 |
| Operating Expenses
| 828.175 | 599.323 | 454.598 | 295.23 | 179.524 | 180.693 | 136.223 | 99.768 | 92.578 | 96.384 | 89.872 | 69.421 |
| Operating Income
| 595.216 | 440.403 | 265.834 | 183.114 | 143.154 | 94.629 | 68.105 | 32.979 | 27.306 | 26.214 | 17.718 | -12.029 |
| Operating Income Ratio
| 0.109 | 0.115 | 0.098 | 0.1 | 0.129 | 0.08 | 0.074 | 0.047 | 0.047 | 0.051 | 0.036 | -0.056 |
| Total Other Income Expenses Net
| -5.592 | 0.129 | 2.169 | 0.228 | -0.29 | -0.285 | -0.475 | 0.047 | 3.717 | 0.489 | 4.96 | 2.523 |
| Income Before Tax
| 589.623 | 440.532 | 268.003 | 183.341 | 142.864 | 94.344 | 67.63 | 33.027 | 23.95 | 13.279 | 22.678 | -9.506 |
| Income Before Tax Ratio
| 0.108 | 0.115 | 0.099 | 0.1 | 0.129 | 0.08 | 0.073 | 0.047 | 0.041 | 0.026 | 0.046 | -0.044 |
| Income Tax Expense
| 20.799 | 17.144 | 6.815 | 15.21 | 18.606 | 10.423 | 8.657 | 4.372 | 4.524 | 1.601 | 4.156 | -3.561 |
| Net Income
| 528.013 | 401.342 | 258.766 | 168.403 | 124.258 | 83.023 | 60.033 | 30.516 | 20.968 | 12.454 | 16.4 | -4.343 |
| Net Income Ratio
| 0.097 | 0.105 | 0.096 | 0.092 | 0.112 | 0.07 | 0.065 | 0.043 | 0.036 | 0.024 | 0.033 | -0.02 |
| EPS
| 1.88 | 1.47 | 1.01 | 0.66 | 0.48 | 0.32 | 0.38 | 0.2 | 0.14 | 0.08 | 0.14 | 0 |
| EPS Diluted
| 1.86 | 1.43 | 0.98 | 0.66 | 0.48 | 0.32 | 0.38 | 0.2 | 0.14 | 0.08 | 0.14 | 0 |
| EBITDA
| 727.32 | 558.034 | 346.48 | 232.756 | 183.32 | 128.351 | 96.61 | 53.428 | 42.174 | 39.225 | 31.534 | -5.028 |
| EBITDA Ratio
| 0.133 | 0.146 | 0.128 | 0.127 | 0.165 | 0.108 | 0.105 | 0.076 | 0.073 | 0.077 | 0.063 | -0.023 |